Longeveron Inc is a clinical-stage biotechnology company based in Miami, FL, specializing in the development of cellular therapies for aging-related and life-threatening conditions. Their research and therapies focus on improving healthspan, the number of years a person is expected to live in good health, free from chronic disease and disabilities of aging. Longeveron is at the forefront of stem cell research, aiming to enhance the quality of life during the aging process and offer improved treatment options for patients with conditions such as Alzheimer's disease and Hypoplastic Left Heart Syndrome.
With a patient-focused approach, Longeveron is dedicated to developing therapeutics derived from cells within our own body, which have the ability to repair and regenerate damaged tissue. Through their clinical trials and partnerships, they are leading the way in finding innovative solutions for life-threatening conditions that affect millions of people worldwide. Longeveron's mission is to harness the potential of cellular therapy to restore and rejuvenate, ultimately improving the health and well-being of individuals as they age.
Generated from the website